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Abstract
 
Human macrophages mediate the dissolution of elastic lamina by mobilizing tissue-destructive
cysteine proteinases. While macrophage-mediated elastin degradation has been linked to the
expression of cathepsins L and S, these cells also express cathepsin K, a new member of the cys-
teine proteinase family whose elastinolytic potential exceeds that of all known elastases. To de-
termine the relative role of cathepsin K in elastinolysis, monocytes were differentiated under
conditions in which they recapitulated a gene expression profile similar to that observed at sites
of tissue damage in vivo. After a 12-d culture period, monocyte-derived macrophages (MDMs)
expressed cathepsin K in tandem with cathepsins L and S. Though cysteine proteinases are aci-
dophilic and normally confined to the lysosomal network, MDMs secreted cathepsin K extra-
cellularly in concert with cathepsins L and S. Simultaneously, MDMs increased the expression
 
of vacuolar-type H
 
1
 
-ATPase components, acidified the pericellular milieu, and maintained ex-
tracellular cathepsin K in an active form. MDMs from a cathepsin K–deficient individual, how-
ever, retained the ability to express, process, and secrete cathepsins L and S, and displayed nor-
mal elastin-degrading activity. Thus, matrix-destructive MDMs exteriorize a complex mix of
 
proteolytic cysteine proteinases, but maintain full elastinolytic potential in the absence of cathep-
sin K by mobilizing cathepsins L and S.
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Introduction
 
In inflammatory disease states, the destruction of elastin-
rich tissues is associated with the local accumulation of
macrophages that express heightened levels of a diverse mix
of proteolytic enzymes (1–6). Because elastin is resistant to
most forms of proteolytic attack and its dissolution can irre-
versibly modify tissue structure and/or function, increased
 
attention has focused on identifying the subset of macro-
phage-derived proteinases that participate in the elastino-
lytic process (1–6). Within the papain–cysteine protease fam-
ily, the only elastinolytic proteinases previously known to
be expressed in human macrophages were cathepsins L and S
(6, 7). However, a new cysteine proteinase, termed cathep-
sin K, has been identified in human macrophages in vitro as
well as in vivo, and the isolated enzyme has been shown to
express an elastin-degradative potential that exceeds that of
all other mammalian elastases (6, 8–11). Furthermore, as
cathepsin K–positive
 
 
 
human macrophages have been found
in juxtaposition to sheets of fragmented elastin in athero-
sclerotic lesions in vivo, it has been proposed that inflam-
matory cells may use this proteinase to degrade the elastic
lamina (4, 5).
 
Despite the tissue-destructive potential of cathepsin K,
cysteine proteinases are normally routed to acidic endoso-
mal/lysosomal compartments (6). In these intracellular vesi-
 
cles, cathepsin K, which displays a pH optimum of 
 
z
 
6.0,
expresses maximal enzyme activity and is shielded from de-
naturation at neutral pH (6, 12–14). However, given its in-
tracellular trafficking pattern and enzymatic properties, it
remains unclear as to whether intact cells can secrete active
cathepsin K or use the proteinase to mediate extracellular
elastinolysis. To this end, we have characterized cathepsin
K expression, processing, and secretion in human mono-
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cyte-derived macrophages (MDMs)
 
1
 
 that have been cul-
tured under conditions in which the fully differentiated
cells display a tissue-destructive phenotype similar to that
observed in chronic inflammatory sites in vivo. Our find-
ings demonstrate that MDMs can constitutively secrete fully
processed cathepsin K into the extracellular space where the
proteinase retains enzymic activity. Coincident with the se-
cretion of active cathepsin K, cDNA microarray analysis
demonstrated that MDMs upregulated expression of vacu-
olar-type H
 
1
 
-ATPase components, which allowed the cells
to create a pericellular acidic milieu conducive to optimal
cysteine proteinase activity. Finally, by taking advantage of
the recent observation that patients with an osteochondro-
dysplastic syndrome, pycnodysostosis, harbor mutations in
the cathepsin K gene (15, 16), we have generated cathepsin
K–deficient MDMs to assess the relative role of this cysteine
proteinase in macrophage-mediated elastinolysis.
 
Materials and Methods
 
Macrophage Preparation.
 
Monocytes were adherence purified
and cultured in RPMI 1640 (GIBCO BRL) supplemented with
either 40% autologous serum or pooled AB serum and 100 U
penicillin, 50 U streptomycin, and 2 mM 
 
l
 
-glutamine for 12 d as
described (7). Where indicated, 12-d-old MDMs were incubated
alone or with 0.25 mg/ml zymosan particles (Sigma-Aldrich), 3
 
m
 
m latex beads (a 1:10 dilution of a 10% suspension; Sigma-
Aldrich), 50 ng/ml tetradecanoylphorbol 13-acetate (TPA; Sigma-
Aldrich), 5 
 
m
 
M nocodazole, 4 
 
m
 
M taxol, 5 
 
m
 
M cytochalasin D,
5–10 
 
m
 
M bafilomycin A
 
1
 
, or 50 nM folimycin (all from Calbio-
chem-Novabiochem).
 
Northern Blot Analysis.
 
Total RNA was isolated from mac-
rophage cultures using TRIzol reagent (GIBCO BRL) and re-
solved by 1% agarose gel electrophoresis (7). Cross-linked mem-
branes were then probed for osteopontin, human cartilage
glycoprotein (gp)-39, chitotriosidase, cathepsins K, B, S, or L, or
glyceraldehyde 3-phosphate dehydrogenase
 
 (
 
GAPDH). The fol-
lowing probes were synthesized: osteopontin (bp 371–2709;
sequence data available from EMBL/GenBank/DDBJ under acces-
sion no. U20758.1), gp-39 (bp 124–1278; accession no. NM-
001276.1), chitotriosidase (bp 10–1413; accession no. U29615.1),
cathepsin K (bp 139–1134; accession no. S79895.1), cathepsin B
(bp 175–1200; accession no. L16510.1), cathepsin S (bp 134–
1135; accession no. M90696.1), cathepsin L (bp 131–1138; acces-
sion no. M20496.1), and GAPDH (bp 48–1016; accession no.
M17851.1).
 
Western Blot Analysis.
 
To assess intracellular cysteine protease
content, monocyte/MDM extracts were prepared after lysis with
1% Triton X-100 (Sigma-Aldrich) in PBS (GIBCO BRL) sup-
plemented with a protease inhibitor cocktail (Calbiochem-Nova-
biochem). For secreted proteinases, cultures were switched to
serum-free media at indicated times and supernatants were
collected after an additional 48-h culture period. During the in-
cubation in serum-free media, MDMs released 
 
,
 
0.5% of their
total lactate dehydrogenase activity as determined according to
the manufacturer’s protocol (Sigma-Aldrich). Samples were then
 
treated with the protease inhibitor cocktail and centrifuged (5
min at 10,000 
 
g
 
) to remove cell debris. Equal amounts of protein
(10 
 
m
 
g) were loaded under reducing conditions onto a 12.5%
SDS-polyacrylamide gel and transferred as described (7). The
membranes were then incubated with either cathepsin K mAb
3021 (16), mouse anti–human cathepsin B mAb IM-27L (Calbio-
chem-Novabiochem), rabbit anti–human cathepsin S polyclonal
Ab (a gift of H.A. Chapman, University of California at San
Francisco, San Francisco, CA), rabbit anti–human cathepsin L
(Athens Research & Technology), or rabbit anti–human cathep-
sin D (Dako). The bound primary Abs were then tagged with
horseradish peroxidase–conjugated species-specific secondary Abs
(Pierce Chemical Co.) using the SuperSignal West Pico system
(Pierce Chemical Co.).
 
Vacuolar-type H
 
1
 
-ATPase mRNA and Protein Expression.
 
La-
beled cRNA was prepared as described, hybridized on Affyme-
trix oligonucleotide arrays, and scanned (17). Triton X-100 ex-
tracts were immunoblotted with a mouse mAb (3.2 Fl; a gift of
M. Forgase, Boston University, Boston, MA) directed against the
catalytic A subunit or the vacuolar-type H
 
1
 
-ATPase. Bovine
brain extract was used as a positive control.
 
Detection of Cathepsin K–Cystatin C Complexes and Lysosomal
Hydrolase Activity.
 
To identify cathepsin K–cystatin C com-
plexes, cells were incubated in serum-free media for 24 h in the
absence or presence of human cystatin C (100 
 
m
 
g/ml; Calbio-
chem-Novabiochem) with or without the general cysteine pro-
teinase inhibitor, E-64 (100 
 
m
 
M; Sigma-Aldrich). Supernatants
were collected, treated with the protease inhibitor cocktail, and
cellular debris was removed by centrifugation (5 min at 10,000 
 
g
 
).
The supernatants were precleared (2 h at 4
 
8
 
C) with 20 
 
m
 
l of Pro-
tein A/Plus Protein G 50% agarose slurry (Calbiochem-Novabio-
chem) and then incubated with rabbit anti–cystatin C polyclonal
antisera (Calbiochem-Novabiochem) or control antisera for 12 h
at 4
 
8
 
C. Cystatin C–anticystatin complexes were immunoprecipi-
tated with 20 
 
m
 
l of Protein A/Plus Protein G 50% agarose slurry
(2 h at 4
 
8
 
C) and bound proteins were eluted under nonreducing
conditions. The samples were then loaded onto a 12.5% SDS-
polyacrylamide gel, resolved under nonreducing conditions, and
immunoblotted with anti–cathepsin K mAb.
 
Electron and Confocal Laser Microscopy.
 
For scanning electron
microscopy, monocyte and/or MDM cultures were fixed in 2%
glutaraldehyde and 4% paraformaldehyde in 0.1 M sodium ca-
codylate buffer (pH 7.4). After postfixation with 1% osmium ox-
ide (Electron Microscopy Sciences), the cells were dehydrated in
ethyl alcohol, transferred to hexamethyl-disilizane, and air-dried
before gold sputtering. For transmission electron microscopy
(TEM), cells were fixed in 2% glutaraldehyde and 1.5%
paraformaldehyde in 0.1 M sodium cacodylate buffer (pH 7.4).
After postfixation with 1% osmium oxide and dehydration in
ethyl alcohol, samples were embedded in epoxy resin and stained
with uranyl acetate and lead citrate (18). In selected experiments,
the surface plasma membrane of fixed cells was stained with ei-
ther 0.1% ruthenium red or 0.4 mg/ml cationized ferritin
(Sigma-Aldrich), and then processed for TEM (19, 20).
To visualize acidified microenvironments, MDMs cultured in
the presence or absence of elastin particles were incubated in se-
rum-free media with 10 
 
m
 
g/ml acridine orange (Sigma-Aldrich)
for 15 min at 37
 
8
 
C (21, 22). In selected experiments, MDM–elas-
tin cocultures were preincubated with 5 
 
m
 
m bafilomycin for 4 h
at 37
 
8
 
C to inhibit the vacuolar-type H
 
1
 
-ATPase (22, 23) before
treatment with acridine orange. Vital confocal fluorescence mi-
croscopy was performed on a Bio-Rad MRC 600 using a 488-nm
excitation wavelength from an argon ion laser. Extracellular
 
1
 
Abbreviations used in the paper:
 
 GAPDH, glyceraldehyde 3-phosphate de-
hydrogenase; gp, glycoprotein; MDM, monocyte-derived macrophage;
TEM, transmission electron microscopy; TPA, tetradecanoylphorbol 13-
acetate. 
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versus intracellular fluorescence was distinguished by using trypan
blue as an extracellular quencher (24).
 
Elastin Degradation.
 
12-d-old MDMs prepared from normal
patients, the haplosufficient parents, or the affected child (for de-
tails of the mutations, see reference 16) were incubated with 8
mg 
 
3
 
H-labeled elastin particles (type E60; Elastin Products Co.)
in the absence or presence of either 100 
 
m
 
m E-64 (7) or 5 
 
m
 
M
bafilomycin A
 
1
 
. After a 0–48-h incubation, supernatants were re-
covered, centrifuged (10 min at 10,000 
 
g
 
), and solubilized elastin
was quantified by scintillation counting (7). Results are expressed
as micrograms of elastin degraded/10
 
6
 
 cells/24 h assuming a spe-
cific activity of 1,100 cpm/
 
m
 
g elastin.
 
Results
 
Cathepsin K Expression by Human MDMs.
 
In inflamma-
tory disease states, human macrophages have been shown
to differentially express mRNA for several gene products
which include not only cathepsin K, but also the matrix
protein osteopontin as well as members of the glycosyl hy-
drolase family (e.g., gp-39 and chitotriosidase [25]). In an
attempt to recapitulate a differentiation program similar to
that observed at inflammatory sites in vivo, peripheral
blood monocytes were cultured for 12 d in 40% autologous
serum wherein the cells underwent marked morphologic
changes (Fig. 1 A). Coincident with this process, MDMs
displayed a profile of increased gene expression that mim-
icked that observed in vivo with increased expression of os-
teopontin, gp-39, and chitotriosidase (Fig. 1 B). Likewise,
the MDMs markedly increased mRNA expression for
cathepsin K (Fig. 2 A). Although MDMs also increased
mRNA levels of cathepsins B, S, and L, their patterns of
expression were distinct from that of cathepsin K (Fig. 2 B).
Cysteine proteinases are synthesized as zymogens and
undergo maturation to their enzymatically active forms
during transport from the trans-Golgi network to the late
endosome/lysosomal compartments (6). In Fig. 3, Western
blot analyses of whole cell lysates from monocytes or
 
MDMs identified the cathepsin K proform (
 
z
 
38 kD) and
processed mature form (
 
z
 
27 kD), as well as an 
 
z
 
15-kD
derivative at day 12 that may represent a degradation prod-
uct of the mature enzyme. While a similar pattern of ex-
pression was noted for cathepsin S, with the pro- and ma-
ture forms detected at day 12, the pro- and/or active forms
of cathepsins B and L began to accumulate intracellularly
within 5 d (Fig. 3).
 
MDM Secretion of Pro- and Mature Forms of Cathepsin K.
 
Cathepsins B, S, and L can be expressed by diverse cell
types in vitro or in vivo, but the mature forms of these en-
zymes are usually stored intracellularly (6, 7, 26). Nonethe-
less, analyses of cell-free supernatants from MDMs demon-
strate that the cells acquired the ability to secrete both the
pro- and mature forms of cathepsin K as well as those of
cathepsins B, S, and L, albeit with distinct kinetics (Fig. 4
Figure 1. The in vitro  differentiation of MDMs. (A)
Scanning electron micrographs of differentiating monocytes
after 2 h, and 3, 5, 7, and 12 d of culture. Bar, 10 mm. (B)
Northern blot analysis of osteopontin, gp-39, and chitotri-
osidase mRNA expression during MDM differentiation.
Results are shown from an experiment performed using total
RNA pooled from five donors. Equal loading was deter-
mined by GAPDH mRNA hybridization (not shown).
Figure 2. Northern blot analysis of cysteine proteinase expression dur-
ing MDM differentiation. (A) Total RNA was extracted at the indicated
time points and hybridizations were performed using probes for cathep-
sins K, B, S, and L. Results are shown from an experiment performed us-
ing total RNA pooled from five donors. (B) The levels of mRNA expres-
sion of each cathepsin mRNA were compared with those of GAPDH
mRNA at the indicated time points. Data are presented as percentage of
maximal expression of each cathepsin mRNA: cathepsin K (j), cathepsin
B (m), cathepsin S (d), and cathepsin L (h). 
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A). Whereas cathepsins K and L were initially secreted as
both pro- and mature forms (at days 5 and 3, respectively),
cathepsins B and S were first detected extracellularly as pro-
forms alone (Fig. 4 A). Consistent with reports that lysoso-
mal enzymes may be packaged and mobilized from separate
intracellular compartments (27–29), the secretion of the ly-
sosomal hydrolase, 
 
b
 
-glucosaminidase, was detected in
3-d-old MDMs despite the fact that mature forms of cathep-
sins K, B, and S were not yet released (Fig. 4, B versus A).
Likewise, whereas the aspartyl proteinase, procathepsin D,
was secreted through day 5, the 
 
z
 
32-kD mature form of
the enzyme (30) was only released from MDMs after 7 d in
culture (Fig. 4 C). Thus, while 12-d-old MDMs mobilized
mature forms of cysteine proteinases, a lysosomal hydrolase
and an aspartyl proteinase, the secretory phenotype for each
of these enzymes was regulated differentially.
To determine whether cathepsin K secretion could be
modulated, MDMs were incubated with either opsonized
zymosan particles, latex beads, or TPA (27). However,
none of these stimuli affected cathepsin K secretion (Fig. 5,
A and C). Similarly, although calcium ionophores have
been reported to trigger lysosomal enzyme release in vari-
ous cell populations (31), no effects were seen on the secre-
tion of either proform or mature cathepsin K (Fig. 5 C). A
functional microtubular network has been linked to cathep-
sin B secretion in tumor cells (32), but neither nocodazole
nor taxol affected cathepsin K or B secretion (Fig. 5, B and
D). Finally, because the cortical actin network has been
proposed to act as a physical barrier to granule docking
(33), we finally assessed the role of cytochalasin D on exo-
cytosis. Significantly, MDMs incubated with cytochalasin
alone markedly increased cathepsin K as well as B secretion
(Fig. 5, B and D; similar results were obtained with cathep-
sins S and L, data not shown). These findings suggest that
MDMs are “primed” for exocytosis, but that the actin net-
work acts as a dominant negative clamp (33).
Figure 3. Intracellular cysteine proteinase expression during MDM dif-
ferentiation. Cell lysates (10 mg/lane) were harvested at 2 h, and 3, 5, 7,
and 12 d, and immunoblotted with anti–cathepsin K, B, S, and L Abs.
The pro- (white arrowheads) and mature (arrows) forms of the enzymes
are highlighted. Mature cathepsin B is expressed as a single and two chain
active form (Mr z31 and z25 kD, respectively; see reference 7). Results
are shown from a single representative experiment of three performed.
Figure 4. The secretory phenotype of MDMs. (A) Western blot analy-
sis of cathepsins K, B, S, and L secreted by MDMs at the indicated time
points. (B) Supernatants collected as above were analyzed for release of b-glu-
cosaminidase or (C) cathepsin D. In A and C, each lane was loaded with
10 mg total protein and the pro- (white arrowheads) and mature (arrows)
forms of the enzymes are indicated. Results are shown from a single rep-
resentative experiment of three performed.
Figure 5. Regulation of cathepsin K secretion in MDMs. 12-d-old
MDMs were incubated for 48 h in serum-free media alone or in the pres-
ence of (A) zymosan (0.25 mg/ml) or latex beads (1:10 dilution of a 10%
suspension), (B) nocodazole (5 mM), taxol (4 mM), or cytochalasin D (5
mM), or (C) TPA (50 ng/ml) or ionomycin (1 M). Cathepsin K secretion
into the cell-free supernatants was assessed by Western blot analysis in A,
B, and C, and cathepsin B in D. The pro- (white arrowheads) and mature
(arrows) forms of the enzymes are indicated. Results are shown from a
single representative experiment of three performed. 
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Figure 6. Detection of acidic mi-
croenvironments in MDM–elastin
cocultures. 12-d-old MDMs were
either incubated alone (A) or with 2
mg elastin (B) and examined by
scanning electron microscopy. (C
and D) Cells were incubated with
elastin for 24 h and stained with ei-
ther 0.1% ruthenium red or 0.4 mg/
ml cationized ferritin, respectively,
and processed for TEM. Micro-
graphs were taken at 3300, 3750,
310,200, and 310,100, respec-
tively, with asterisks overlying elastin
and arrows pointing to ruthenium
red– or ferritin-stained plasma mem-
brane. MDMs incubated alone (E)
or with elastin for z16 h (F, G, and
H) were treated with 10 mg/ml acri-
dine orange and the cells were
viewed by confocal laser micros-
copy. Acidic environments fluo-
resce orange-red while green fluo-
rescence represents nonspecific
association with nucleic acids and
unacidified elastin particles (refer-
ence 22). The solid white lines out-
line MDMs; the dotted white lines
outline elastin particles in each con-
focal section. The fluorescence ob-
served surrounding the elastin parti-
cles (F) was completely quenched by
trypan blue (G). (H) MDMs pre-
treated with 5 mm bafilomycin A1
(4 h at 378C) did not acidify cellular
compartments as assessed by acridine
orange fluorescence. (Inset) Lysates
from z3  3 104 12-d-old MDMs
(lane 1) were immunoblotted with
an mAb (3.2 Fl) to the 73-kD cata-
lytic subunit of the vacuolar-type
H1-ATPase. Bovine brain extract
(lane 2) served as a positive control.
 
MDMs Generate an Acidic Pericellular Environment during
Elastinolysis.
 
Given the ability of fully differentiated
MDMs to constitutively secrete cathepsin K along with a
complement of other acidophilic enzymes, we considered
the possibility that the macrophages purposely acidify their
pericellular space to optimize extracellular proteolytic/hy-
drolytic activity. As shown in Fig. 6, 12-d-old MDMs (Fig.
6 A) efficiently blanket large particles of insoluble elastin
(Fig. 6 B). TEM analysis demonstrated that the MDM
membrane is tightly applied to the surface of the elastin par-
ticles (Fig. 6, C and D). To determine whether this interface
 
creates a sequestered environment, MDM–elastin cultures
were cooled to 4°C, fixed, and incubated briefly with either
a small or large molecular-sized probe (i.e., ruthenium red at
 
z
 
0.6 kD or cationized ferritin at 
 
z
 
500 kD), and access to
the interface was assessed by TEM (19, 20). As shown in Fig.
6, the extracellular macrophage–elastin interface was readily
stained by ruthenium red (Fig. 6 C). In contrast, cationized
ferritin stained the external face of the MDM plasma mem-
brane, but was excluded from the zone of contact (Fig. 6 D).
Given the tight cleft formed between the macrophage
membrane and the elastin surface, we next determined 
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whether an acidified zone might be visualized with the aci-
dotrophic dye, acridine orange (21, 22). As expected, con-
focal laser micrographs of MDMs incubated with the dye
alone displayed the orange-red, intracellular staining pat-
tern characteristic of the acidified endosomal and lysosomal
compartments (Fig. 6 E). In the presence of elastin parti-
cles, however, additional areas of orange-red fluorescence
appeared as lacunar islands surrounding the cell-bound elas-
tin particles (Fig. 6 F). The extracellular localization of
these acidified zones was confirmed by the ability of the
membrane-impermeable fluorescence quencher, trypan blue,
to selectively inhibit lacunar, but not intracellular, fluores-
cence (Fig. 6 G).
The vacuolar-type H
 
1
 
-ATPase is a multisubunit enzyme
system implicated in the acidification of intracellular as well
as extracellular compartments in a wide range of cell types
(34, 35). To determine whether monocyte/macrophage
differentiation was associated with the upregulation of vac-
uolar-type H
 
1
 
-ATPase components, RNA was extracted
from monocytes and 1-, 6-, or 12-d-old MDMs, and la-
beled cRNA was prepared and hybridized to oligonucle-
otide microarrays (17). As shown in Fig. 7, MDMs in-
creased expression of at least four components of the
vacuolar-type H
 
1
 
-ATPase, including the B, F, E, and a
subunits. Western blot analysis of fully differentiated MDMs
with an mAb directed against the 73-kD catalytic A subunit
confirmed the presence of vacuolar-type H
 
1
 
-ATPase com-
ponents at the protein level (Fig. 6, inset). Consistent with
these results, when MDMs were treated with the specific
vacuolar-type H
 
1
 
-ATPase inhibitor, bafilomycin A
 
1
 
 (22,
35), neither the intracellular nor extracellular compartments
were acidified as assessed by acridine orange staining (Fig. 6
H). Under these conditions, elastin degradation by 12-d-
old MDMs (see below) that had been pretreated with ba-
filomycin A
 
1
 
 for 4 h was inhibited by 89 
 
6 2% (mean 6 1
SD; n 5 4).
Secretion of Enzymatically Active Cathepsin K by MDMs.
The formation of an acidified pericellular zone could po-
tentially serve to stabilize cathepsin K activity extracellu-
larly. Although we have previously used an active site affin-
ity label to detect active cathepsin B, S, and L secretion
from MDMs (7), the diazomethane ketone probe only
poorly reacts with active cathepsin K (data not shown).
However, MDMs secrete the potent cysteine proteinase
inhibitor, cystatin C, which tightly binds active cysteine
proteinases (5, 6, 36). Thus, we reasoned that extracellular
cathepsin K–cystatin complexes might be formed if active
cathepsin K was excreted. Therefore, MDM supernatants
were incubated with anti–cystatin C polyclonal antisera,
the immunoprecipitates were resolved by SDS-PAGE, and
complexed cathepsin K was probed by Western blot analy-
sis. As shown in Fig. 8 A, mature cathepsin K was readily
detected in the cystatin C immunoprecipitates (lane 2, ar-
rowhead). Similarly, cathepsin K complexes were detected
when intact MDMs were cultured in the presence of exog-
enous cystatin C (lane 6). Consistent with the ability of
cystatin to form complexes with active cysteine proteinases
alone, cathepsin K–cystatin C adducts were not detected
when MDMs were cultured in the presence of the cysteine
proteinase inhibitor, E-64, either with or without exoge-
nous cystatin C (Fig. 8 A, lanes 8 and 4, respectively). Sig-
nificantly, E-64 did not inhibit cysteine proteinase secre-
tion per se, as increased quantities of mature cathepsin K
Figure 7. Vacuolar-type H1-
ATPase component expression
in MDMs. Total RNA was ex-
tracted from monocytes or
MDMs at the indicated times
and components B (h), a (e), E
(s), and F (n) quantified by
cDNA microarray analysis. Re-
sults are shown as the mean fold
increase in mRNA content rela-
tive to that expressed by freshly
isolated monocytes from a single
representative experiment of
three performed.
Figure 8. Identification of extracellular cathepsin K–cystatin C com-
plexes in MDM cultures. (A) 12-d-old MDMs were incubated for 48 h
in serum-free media (lanes 1–4) or serum-free media supplemented
with human cystatin C (100 mg/ml; lanes 5–8). Cystatin C or cathepsin
K–cystatin complexes were immunoprecipitated using rabbit preimmune
sera (lanes 1, 3, 5, and 7) or a specific anti–cystatin C Ab (lanes 2, 4, 6,
and 8). Immunoprecipitates were then resolved by SDS-PAGE, trans-
blotted, and probed with an anti–cathepsin K mAb. In lanes 2 and 6, ma-
ture cathepsin K (black arrowhead) was identified as a complex with en-
dogenous or exogenous cystatin C, respectively. When MDMs were
incubated with 100 mM E-64 during the 48-h culture period (lanes 3, 4,
7, and 8), secreted cathepsin K was inactivated and did not form com-
plexes with cystatin C. Nonspecific bands are observed as a consequence
of a spurious cross-reaction of the secondary Abs with the rabbit poly-
clonal antisera used to immunoprecipitate cystatin C. Results are shown
as a single representative experiment of two performed. (B and C) 12-d-
old MDMs were incubated for 48 h in serum-free media alone or in the
presence of E-64 (100 mM), bafilomycin A1 (10 mM), or folimycin (50
nM) and the supernatants were examined for cathepsin K (B) or cathep-
sin B (C) secretion. The pro- (white arrowheads) and mature (arrows)
forms of the enzymes are indicated. Results are shown as a single repre-
sentative experiment of three performed.795 Punturieri et al.
(Fig. 8 B, lane 2) or the single chain active form of cathep-
sin B (Fig. 8 C, lane 2) were detected under these condi-
tions. (The ability of E-64 to inhibit the processing of sin-
gle chain, active cathepsin B to its two chain form has been
described [37].) While the vacuolar-type H1-ATPase in-
hibitors, bafilomycin A1 or folimycin, would be predicted
to affect cathepsin K extracellular activity by disrupting
pericellular acidification (22, 23, 35), intracellular acidifica-
tion plays a key role in regulating the maturation of cys-
teine proteinase zymogens, membrane transport processes,
as well as their mannose 6-phosphate receptor–mediated
trafficking to the lysosomal compartment (6, 28, 29, 35).
Consequently, MDMs cultured in the presence of vacu-
olar-type H1-ATPase inhibitors secreted only proforms of
cathepsin K or B extracellularly (Fig. 8, B and C), and ef-
fects on the enzymatic activity of mature extracellular
cathepsins could not be determined.
Cysteine Proteinase Processing and Elastinolytic Activity in
Cathepsin K–deficient Macrophages. Given the ability of
MDMs to secrete active cathepsin K, we next sought to
determine whether the proteinase played a necessary role in
extracellular elastinolysis by monitoring the functional ac-
tivity of cathepsin K–deficient macrophages derived from
the peripheral blood of a patient with pycnodysostosis (15,
16). As the affected individual is a compound heterozygote
(16), we first examined cell lysates and supernatants for evi-
dence of residual cathepsin K expression. In 12-d-old
MDMs, only trace amounts of procathepsin K can be de-
tected intracellularly or extracellularly relative to controls
(Fig. 9 A). Significantly, cathepsin K deficiency did not af-
fect the intracellular content or secretion of cathepsins S or
L (Fig. 9 A). We did note, however, that pycnodysostosis-
derived MDMs (a) both contained and secreted smaller
quantities of cathepsin B and (b) secreted multiple forms of
procathepsin L (Fig. 9 A). Because the secretion of the elas-
tinolytic cysteine proteinases, cathepsins S and L, were un-
affected by cathepsin K mutations (cathepsin B does not
degrade elastin [7]), 12-d-old MDMs derived from a con-
trol, a haplosufficient parent with z50% normal levels of
cathepsin K (16), and the affected kindred were incubated
with insoluble elastin in 40% serum and elastinolysis was
quantified. Surprisingly, despite the absence of mature
cathepsin K in the pyknodysostotic MDMs, elastin degra-
dation was unaffected (Fig. 9 B). Cysteine proteinase–inde-
pendent pathways had not compensated for cathepsin K
deficiency in these cells, as E-64 similarly inhibited elastin
degradation by control, carrier, and affected MDMs (Fig. 9
B). Thus, although normal MDMs actively secrete mature
cathepsin K, L, and S, the latter two cysteine proteinases
alone can allow MDMs to maintain their full elastinolytic
potential.
Discussion
After the initial identification of cathepsin K, it was
noted not only that the isolated enzyme could exert a pow-
erful tissue-destructive potential in vitro, but also that its
expression in vivo was associated with both physiologic and
pathologic matrix remodeling events (4–6, 9–12, 38, 39).
Early studies suggested that cathepsin K expression might
be restricted to osteoclasts in vivo (40, 41), but the cysteine
proteinase was subsequently localized to other cell types in-
cluding macrophages, synovial fibroblasts, smooth muscle
cells, pulmonary epithelium, and tumor cells (8–10, 42,
43). Given these findings, it has been largely assumed that
normal or neoplastic cells would secrete the cysteine pro-
teinase into the extracellular milieu for the purpose of de-
grading extracellular matrix components. Interestingly,
however, no cell type, including the osteoclast, has been
shown to either secrete the fully processed, mature form of
Figure 9. The cysteine proteinase expression and elastinolytic activity
of normal versus pyknodysostotic MDMs. (A) Western blot analysis of
cathepsin K (lanes 1–4), cathepsin B (lanes 5–8), cathepsin S (lanes 9–12),
and cathepsin L (lanes 13–16) expression in 12-d-old MDMs from a nor-
mal control (lanes 1, 3, 5, 7, 9, 11, 13, and 15) or a pyknodysostotic do-
nor (lanes 2, 4, 6, 8, 10, 12, 14, and 16). Cell lysates (lanes 1, 2, 5, 6, 9,
10, 13, and 14) or cell-free supernatants (lanes 3, 4, 7, 8, 11, 12, 15, and
16) (all 10 mg/lane) were immunoblotted with the respective Abs. The
pro- (white arrowheads) and mature (arrows) forms of cathepsins K, B, S,
and L are identified as shown. (B) MDM-mediated 3H-elastin degrada-
tion. The elastinolytic activity of cells derived from a healthy donor (lanes
1 and 2), an unaffected heterozygous individual (lanes 3 and 4), or an af-
fected subject (lanes 5 and 6) was evaluated in the absence (lanes 1, 3, and
5) or presence (lanes 2, 4, and 6) of 100 mM E-64. Results are shown
from a single experiment.796 Cathepsin K Secretion by Human Macrophages
cathepsin K or regulate the enzyme’s activity extracellu-
larly. Nonetheless, recent reports have documented the ex-
pression of cathepsin K in macrophages at sites of elasti-
nolytic damage in atherosclerotic vessels in vivo coupled
with an associated perturbation of the cysteine proteinase–
cystatin axis (4, 5). Hence, we sought to determine (a) the
ability of MDMs to express, process, and secrete active
cathepsin K and (b) the relative role that cathepsin K plays
in MDM-dependent elastinolysis.
To generate MDMs that recapitulate the destructive
phenotype associated with inflammatory disease states in
vivo, peripheral blood monocytes were cultured in the
presence of high concentrations of autologous sera atop a
plastic substratum. Under these conditions, macrophages
display striking elastinolytic activity while simultaneously
displaying a profile of gene products similar to that previ-
ously localized to macrophages at sites of tissue damage in
vivo (7, 25). During the differentiation process, cathepsin
K mRNA and protein expression were markedly upregu-
lated with kinetics distinct from that observed with cathep-
sins B, L, and S. Though the cathepsin K and cathepsin S
genes lie within 150 kb of each other on chromosome
1q21, and appear to have arisen from a common ancestral
cysteine proteinase, their expression patterns were diver-
gent (44, 45). Relevant to macrophage differentiation, the
cathepsin K promoter contains AP-1, PU.1, and H-APF-1
regulatory elements (44, 45), but which, if any, of the
binding sites participate in late onset gene expression re-
mains to be determined.
Coincident with the upregulation of cathepsin K
mRNA levels, MDMs began to express the cathepsin K
protein. Like the other cysteine proteinases, cathepsin K is
synthesized as a proenzyme that undergoes processing to its
mature form presumably during transit from the trans-
Golgi network to the late endosomal/lysosomal compart-
ments (6, 26). At the earliest time points when cathepsin K
protein could be detected (i.e., between days 3 and 5),
MDMs secreted only small amounts of procathepsin K in
concert with the proforms of cathepsins B and S. While
cysteine proteinases are primarily routed to the late endo-
some/lysosomal compartments by both mannose 6-phos-
phate receptor–dependent and –independent pathways, ly-
sosomal proteinases can escape this delivery process and be
secreted as proforms after exit from the trans-Golgi net-
work (6, 26, 46, 47). We cannot, however, rule out the
possibility that proforms may be secreted in a regulated
fashion from an intracellular compartment (e.g., early en-
dosome or a granule-like vesicle) (28, 29, 47, 48). Interest-
ingly, whereas the cysteine proteinases, cathepsins K, S, B,
and the aspartyl proteinase, cathepsin D, initially exited the
cell predominately as proforms, cathepsin L was preferen-
tially released as the mature enzyme. These findings sup-
port recent reports that the distribution of cysteine protein-
ases in intracellular compartments varies between early
endosome, late endosome, and lysosomal pools (28, 29).
Furthermore, as the secretion of cysteine proteinases as well
as acid hydrolases such as b-glucosaminidase, acid phos-
phatase, and b-glucuronidase can each be regulated in se-
lective fashion (e.g., 27–29, 49), it appears that functionally
distinct pools of lysosomal enzymes may exist in MDMs.
We cannot, however, rule out the possibility that cysteine
proteinases and lysosomal hydrolases failed to accumulate
extracellularly in tandem due to differences in the stability
of the released enzymes or their rate of reuptake (6).
Regardless of the intracellular localization of pro- and
mature forms of lysosomal hydrolases and proteinases,
MDMs ultimately engage a program wherein fully pro-
cessed acidophilic enzymes are actively exteriorized. In
other cell systems, secretion of lysosomal components can
be regulated by particulate or soluble stimuli (27, 48, 49).
Intriguingly, none of these agents altered cysteine protein-
ase secretion despite the fact that these stimuli can affect
lysosomal hydrolase and/or matrix metalloproteinase ex-
pression (data not shown). Cathepsin K secretion was,
however, dramatically upregulated after disassembly of the
actin filament network with cytochalasin. As reviewed by
Muallem et al., cortical actin networks act as a physical bar-
rier to vesicle docking (33). In fusion-competent cells, the
disassembly of the actin network alone is permissive for se-
cretion as we have observed for MDMs. These results con-
trast with other hematopoietic cell types, including neutro-
phils, where actin filament depolymerization alone does
not trigger exocytosis until the cells are specifically trig-
gered by agonists (33). Apparently, the fully differentiated
MDM displays a fusion-competent state wherein the corti-
cal actin network alone may regulate endosome/lysosome–
plasma membrane docking events.
Cathepsins K, L, S, B, and D, and lysosomal hydrolase
each have acidic pH optima and display limited stability in
their mature forms at neutral pH (6, 7, 11, 12). Thus, we
sought to determine whether MDMs might acidify their
pericellular milieu to optimize the proteolytic activity of
lysosomal enzymes. Macrophages can mobilize the vacu-
olar-type H1-ATPase to their plasma membrane, but pri-
mary emphasis has focused on the role of the proton pump
in maintaining cytosolic pH in the face of an external acid
load (e.g., 35, 50). However, it seems likely that the vacu-
olar-type H1-ATPase plays an additional role by creating a
permissive environment for acidophilic enzymes in a man-
ner similar to that described for osteoclasts (35, 51). Indeed,
taking advantage of the formation of a sequestered environ-
ment at the cell–elastin interface where acridine orange
could accumulate, acidified zones were visualized in
MDMs surrounding elastin particles. It should be noted
that the addition of elastin particles was not required for
H1 secretion, as a pericellular pH (monitored by a pH-sen-
sitive microelectrode) of z6.0 was detected in either the
absence or presence of the particles (our unpublished ob-
servation). Likewise, elastin did not alter cysteine protein-
ase release, thus suggesting that MDMs constitutively cose-
crete endosomal/lysosomal contents and pump protons
into the extracellular space after the 12-d differentiation
process. Consistent with this behavior, active cathepsin K
was detected extracellularly as defined by the formation of
cystatin C–cathepsin K complexes. Because cysteine pro-
teinases display short, but finite half-lives at neutral pH (6,797 Punturieri et al.
11, 12), we cannot rule out the possibility that a steady state
concentration of cathepsin K exists in the pericellular mi-
lieu independent of the action of the vacuolar-type H1-
ATPase. As noted, bafilomycin A1 and folimycin disrupt
lysosomal enzyme trafficking and processing (28, 29, 35),
thus obfuscating our ability to define the role of the extra-
cellular pH alone in regulating cathepsin K activity. None-
theless, taken in toto, our data indicate that MDMs can
mobilize all of the necessary machinery to use cathepsin K
as well as cathepsins S and L to express extracellular elasti-
nolytic activity.
Given the ability of MDMs to secrete active cathepsin K
as well as the potent elastinolytic potential of the recombi-
nant proteinase (4–6, 11), it has been assumed that the en-
zyme would play an important role in the elastinolytic pro-
cess. However, cathepsin K–deficient MDMs (as well as
haplosufficient cells expressing one-half normal levels of
cathepsin K) degraded elastin comparably to control cells.
Based on the documented ability of cathepsin K to degrade
insoluble elastin (6, 11), it seems unlikely that the enzyme
fails to participate in MDM-mediated elastin degradation.
Rather, in the absence of cathepsin K, we conclude that
cathepsins L and/or S retain sufficient elastinolytic activity
to compensate fully for the loss of one of the three known
elastases in this gene family. Alternatively, we cannot rule
out the possibility that cathepsin K activity is strictly re-
served for the degradation of a target molecule that is
uniquely sensitive to its action. In human osteoclasts
(which, in contrast to MDMs, express little or no cathepsin
B, L, or S, and do not secrete cathepsin D [14, 41]), cathep-
sin K has been postulated to play a required role in the
degradation of type I collagen or other bone matrix–associ-
ated proteins (11, 12, 15, 38, 39, 52). Furthermore, cathep-
sin K has been shown to degrade type II collagen where it
may play a role in the proteolytic degradation of cartilage
(9, 39). Although our data clearly demonstrate that cathep-
sin K does not play a required role in MDM-mediated elas-
tinolysis, the secretion of this powerful proteinase could
impact on any one of several other extracellular matrix
components.
Macrophages have long been known to secrete lysoso-
mal hydrolases both in vitro and in vivo (27, 49). How-
ever, as the extracellular function of these enzymes has re-
mained largely undefined, the significance of this secretory
phenotype was unclear. Furthermore, as demonstrated, ly-
sosomal hydrolase release may not necessarily correlate
with cysteine or aspartyl proteinase secretion (28, 29).
Nonetheless, our data demonstrate that programs for mobi-
lizing the exocytosis of a more complex, and destructive,
mix of endosomal/lysosomal contents can converge. Taken
together, we posit that the sequestered, acidic microenvi-
ronment generated at the MDM–elastin interface optimizes
proteolytic activity while limiting access to proteinase in-
hibitors. Matrix metalloproteinases have also been impli-
cated in elastin turnover (1, 3), and we have found that
MDMs express several elastinolytic metalloenzymes, in-
cluding gelatinase B, macrophage metalloelastase, and
matrilysin. However, unlike cysteine proteinase–mediated
elastinolysis, we have only been able to implicate matrix
metalloproteinases in elastin degradation under serum-free
conditions (our unpublished observation). In any case,
given that cathepsins K, B, L, and D have all been identi-
fied in tissues actively undergoing destructive tissue remod-
eling (e.g., 9–11, 53–58), it seems likely that the in vitro
MDM phenotype described in our report recapitulates that
expressed in vivo. With the recent demonstration that cyst-
atins may be specifically downregulated at sites of tissue
damage (5), active cysteine proteinases secreted by mac-
rophages and other cell populations (including endothelial
cells, fibroblasts, and tumor cells [55, 56]) may play a more
important role in matrix remodeling than previously sus-
pected.
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